3
Announcements
Trials
Browse
Landscape
Status
Completed
3
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Gynecologic
2
Gastrointestinal
2
Tumor-Agnostic
1
Thoracic
1
Myeloid
1
Lymphoid
1
Genitourinary
1
Conditions
Lymphoma, Large B-Cell, Diffuse
1
Interventions
Cyclophosphamide
139
Rituximab
115
Etoposide
77
Vincristine
75
Doxorubicin
62
Cytarabine
61
Dexamethasone
58
Prednisone
55
fludarabine
52
Methotrexate
46
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
42
Lenalidomide
37
Gemcitabine
35
Radiotherapy
29
Melphalan
27
pegaspargase
22
Prednisolone
22
Ifosfamide
22
fludarabine phosphate
20
Busulfan
20
Cisplatin
19
Bendamustine Hydrochloride
19
Asparaginase
18
Peripheral Blood Stem Cell Transplantation
17
ibrutinib
16
Decitabine
16
Carmustine
16
Mercaptopurine
15
Filgrastim
15
Oxaliplatin
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Base Sequence
×
Lymphoid
×
Clear all
NCT04183569
2020-04-29
PROTEOM
University Hospital, Bordeaux
Unknown
32 enrolled